கால்நடை தடுப்பூசி சந்தை ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Search jobs
22-Feb-2021
Veterinary Vaccine Market will grow at 6.2% CAGR, to be valued at US$ 11,627.46 Million by 2027
Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
, by Technology (Inactivated Vaccines, Toxoid Vaccines, Live Attenuated Vaccines, and Subunit and DNA Vaccines), By Animal Type (Companion (Equine, Canine, and Feline) and Livestock (Bovine, Ovine, Porcine, Poultry, and Others)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 6,766.5 million in 2018 and is expected to exhibit a CAGR of 6.2% over the forecast period (2020-2027). ....

United States , United Kingdom , South Africa , South Korea , Boehringer Ingelheim Gmb , Asia Pacific , Eli Lilly , Merck Animal Health , Rd Center , Veterinary Vaccine Market Press , Blue Buffalo Foundation , Boehringer Ingelheim , Veterinary Vaccine Market Research , Merck Co Inc , Research Objectives , Regeneus Ltd , Animal Cancer Foundation , Karyopharm Therapeutics Inc , Regeneron Pharmaceuticals , Regeneron Pharmaceuticals Inc , Company Overview , Petco Foundation , Research Methodology , Boehringer Ingelheim Vetmedica Inc , Morphogenesis Inc , Technology Inactivated Vaccines ,